Market Cap 154.62M
Revenue (ttm) 6.39M
Net Income (ttm) -117.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,835.05%
Debt to Equity Ratio 0.00
Volume 115,100
Avg Vol 141,558
Day's Range N/A - N/A
Shares Out 14.42M
Stochastic %K 4%
Beta 3.00
Analysts Strong Sell
Price Target $19.00

Company Profile

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson'...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 468 1999
Address:
60 First Street, 2nd Floor Suite 250, Cambridge, United States
PhishTourFunds
PhishTourFunds May. 28 at 12:25 AM
0 · Reply
Estimize
Estimize May. 20 at 10:00 AM
Wall St is expecting -1.24 EPS for $KRRO Q2 [Reporting 08/18 BMO] http://www.estimize.com/intro/krro?chart=historical&metric_name=eps&utm_c
0 · Reply
notreload_ai
notreload_ai May. 18 at 1:45 PM
$KRRO $MBLY $PMI $TJX -- THE WSJ
0 · Reply
Struin
Struin May. 14 at 3:00 PM
$KRRO My favorites Krro, Xeris, MLTX and more ONWRF
0 · Reply
Plechovka
Plechovka May. 12 at 1:47 PM
$KRRO wtf
0 · Reply
focafoca99
focafoca99 May. 7 at 11:13 AM
$KRRO released its March 2026 quarter results via a press release attached to the 8‑K.
0 · Reply
Kevinchristopher09
Kevinchristopher09 May. 1 at 7:12 PM
$KRRO Been here for awhile roughly $6 average. holding for awhile too
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 12:33 PM
$KRRO Share Price: $12.64 Contract Selected: Dec 18, 2026 $10 Calls Buy Zone: $4.51 – $5.58 Target Zone: $8.39 – $10.25 Potential Upside: 75% ROI Time to Expiration: 231 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 29 at 12:41 AM
$KRRO Current Stock Price: $12.81 Contracts to trade: $12.5 KRRO May 15 2026 Call Entry: $0.25 Exit: $0.40 ROI: 60% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StockConsultant
StockConsultant Apr. 16 at 1:04 PM
$ICLR Icon stock, with an upside gap breakout, target 134+, similar setup on $GO $KD $KRRO and $OLMA stocks at https://stockconsultant.com/?ICLR
0 · Reply
Latest News on KRRO
Korro Bio initiated with an Outperform at LifeSci Capital

2026-05-29T10:15:00.000Z - 10 days ago

Korro Bio initiated with an Outperform at LifeSci Capital


Korro Bio selects KRRO-111 as development candidate

2026-05-19T12:15:56.000Z - 20 days ago

Korro Bio selects KRRO-111 as development candidate


Korro Bio initiated with a Buy at Citi

2026-05-18T10:15:06.000Z - 21 days ago

Korro Bio initiated with a Buy at Citi


Korro Bio upgraded to Buy from Hold at JonesResearch

2026-05-08T22:04:21.000Z - 4 weeks ago

Korro Bio upgraded to Buy from Hold at JonesResearch


Korro Bio reports Q1 EPS ($1.69), consensus ($1.98)

2026-05-07T14:40:52.000Z - 4 weeks ago

Korro Bio reports Q1 EPS ($1.69), consensus ($1.98)


Korro Bio Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 weeks ago

Korro Bio Quarterly report: Q1 2026


Korro Bio Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 weeks ago

Korro Bio Earnings release: Q1 2026


Korro Bio Slides: Corporate presentation

May 6, 2026, 7:00 AM EDT - 4 weeks ago

Korro Bio Slides: Corporate presentation


Korro to Participate in Upcoming Investor Conferences

May 5, 2026, 4:05 PM EDT - 4 weeks ago

Korro to Participate in Upcoming Investor Conferences


Korro Bio Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 7 weeks ago

Korro Bio Proxy statement: Proxy filing


Korro Bio Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 7 weeks ago

Korro Bio Proxy statement: Proxy filing


Korro Bio Slides: Corporate presentation

Mar 17, 2026, 7:00 AM EDT - 2 months ago

Korro Bio Slides: Corporate presentation


Korro Bio Registration statement: Registration Filing

Mar 13, 2026, 8:00 AM EDT - 3 months ago

Korro Bio Registration statement: Registration Filing


Korro Bio Earnings release: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 3 months ago

Korro Bio Earnings release: Q4 2025


Korro Bio Annual report: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 3 months ago

Korro Bio Annual report: Q4 2025


Korro Bio prices 4.5M shares at $11.11 in private placement

2026-03-09T11:46:15.000Z - 3 months ago

Korro Bio prices 4.5M shares at $11.11 in private placement


Korro Announces Oversubscribed $85 Million Private Placement

Mar 9, 2026, 7:30 AM EDT - 3 months ago

Korro Announces Oversubscribed $85 Million Private Placement


Korro Bio upgraded to Buy from Hold at Clear Street

2026-02-18T21:31:35.000Z - 3 months ago

Korro Bio upgraded to Buy from Hold at Clear Street


Korro Bio management to meet virtually with Cantor Fitzgerald

2026-01-30T18:00:34.000Z - 4 months ago

Korro Bio management to meet virtually with Cantor Fitzgerald


Korro Bio upgraded to Buy from Neutral at Chardan

2026-01-29T10:00:15.000Z - 4 months ago

Korro Bio upgraded to Buy from Neutral at Chardan


Piper upgrades Korro to Overweight on bullish KRRO-121 view

2026-01-29T09:50:12.000Z - 4 months ago

Piper upgrades Korro to Overweight on bullish KRRO-121 view


Korro Bio upgraded to Overweight from Neutral at Piper Sandler

2026-01-28T23:15:16.000Z - 4 months ago

Korro Bio upgraded to Overweight from Neutral at Piper Sandler


Korro Bio Transcript: Analyst Day 2026

Jan 27, 2026, 8:00 AM EST - 4 months ago

Korro Bio Transcript: Analyst Day 2026


Korro Bio Slides: FY 2026

Jan 27, 2026, 8:00 AM EST - 4 months ago

Korro Bio Slides: FY 2026


Korro to Host Virtual Analyst Day on January 27, 2026

Jan 20, 2026, 8:00 AM EST - 4 months ago

Korro to Host Virtual Analyst Day on January 27, 2026


Korro Bio Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 15, 2026, 1:30 PM EST - 5 months ago

Korro Bio Slides: 44th Annual J.P. Morgan Healthcare Conference


Korro Bio Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 7 months ago

Korro Bio Earnings release: Q3 2025


Korro Bio Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 7 months ago

Korro Bio Quarterly report: Q3 2025


Korro Bio Slides: Corporate presentation

Nov 12, 2025, 7:00 AM EST - 7 months ago

Korro Bio Slides: Corporate presentation


Korro Bio Quarterly report: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 10 months ago

Korro Bio Quarterly report: Q2 2025


Korro Bio Earnings release: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 10 months ago

Korro Bio Earnings release: Q2 2025


Korro Bio Earnings release: Q1 2025

May 7, 2025, 4:00 PM EDT - 1 year ago

Korro Bio Earnings release: Q1 2025


Korro Bio Quarterly report: Q1 2025

May 7, 2025, 4:00 PM EDT - 1 year ago

Korro Bio Quarterly report: Q1 2025


Korro Bio Slides: Corporate Presentation

May 7, 2025, 12:00 PM EDT - 1 year ago

Korro Bio Slides: Corporate Presentation


Korro Bio Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Korro Bio Proxy statement: Proxy Filing


Korro Bio Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Korro Bio Proxy statement: Proxy Filing


Korro Bio Earnings release: Q4 2024

Mar 18, 2025, 7:00 AM EDT - 1 year ago

Korro Bio Earnings release: Q4 2024


Korro Bio Annual report: Q4 2024

Mar 18, 2025, 7:00 AM EDT - 1 year ago

Korro Bio Annual report: Q4 2024


Korro Bio Slides: TD Cowen 45th Annual Healthcare Conference

Mar 4, 2025, 11:50 AM EST - 1 year ago

Korro Bio Slides: TD Cowen 45th Annual Healthcare Conference


Korro Bio Slides: FY 2025

Jan 13, 2025, 6:45 PM EST - 1 year ago

Korro Bio Slides: FY 2025


Korro Bio Registration statement: Registration Filing

Dec 2, 2024, 7:00 AM EST - 1 year ago

Korro Bio Registration statement: Registration Filing


Korro Bio Slides: Corporate Presentation

Nov 25, 2024, 7:00 AM EST - 1 year ago

Korro Bio Slides: Corporate Presentation


Korro Bio Quarterly report: Q3 2024

Nov 12, 2024, 4:00 PM EST - 1 year ago

Korro Bio Quarterly report: Q3 2024


Korro Bio Earnings release: Q3 2024

Nov 12, 2024, 4:00 PM EST - 1 year ago

Korro Bio Earnings release: Q3 2024


Korro Bio Quarterly report: Q2 2024

Aug 14, 2024, 4:00 PM EDT - 1 year ago

Korro Bio Quarterly report: Q2 2024


Korro Bio Earnings release: Q2 2024

Aug 14, 2024, 4:00 PM EDT - 1 year ago

Korro Bio Earnings release: Q2 2024


Korro Bio Slides: Corporate Presentation

May 20, 2024, 7:00 AM EDT - 2 years ago

Korro Bio Slides: Corporate Presentation


Korro Bio Quarterly report: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Korro Bio Quarterly report: Q1 2024


Korro Bio Earnings release: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Korro Bio Earnings release: Q1 2024


Korro Bio Registration statement: Registration Filing

May 14, 2024, 8:00 AM EDT - 2 years ago

Korro Bio Registration statement: Registration Filing


Korro Bio Transcript: The Citizens JMP Life Sciences Conference

May 13, 2024, 12:30 PM EDT - 2 years ago

Korro Bio Transcript: The Citizens JMP Life Sciences Conference


Korro Bio Proxy statement: Proxy Filing

May 1, 2024, 8:00 AM EDT - 2 years ago

Korro Bio Proxy statement: Proxy Filing


Korro Bio Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Korro Bio Proxy statement: Proxy Filing


Korro Bio Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Korro Bio Proxy statement: Proxy Filing


Korro Bio Proxy statement: Proxy Filing

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Korro Bio Proxy statement: Proxy Filing


Korro Announces $70 Million Private Placement

Apr 18, 2024, 8:30 AM EDT - 2 years ago

Korro Announces $70 Million Private Placement


Korro Bio Earnings release: Q4 2023

Mar 26, 2024, 8:00 AM EDT - 2 years ago

Korro Bio Earnings release: Q4 2023


Korro Bio Annual report: Q4 2023

Mar 26, 2024, 8:00 AM EDT - 2 years ago

Korro Bio Annual report: Q4 2023


Korro Bio Slides: Investor Presentation

Mar 13, 2024, 10:00 AM EDT - 2 years ago

Korro Bio Slides: Investor Presentation


Korro Bio Registration statement: Registration Filing

Dec 20, 2023, 7:00 AM EST - 2 years ago

Korro Bio Registration statement: Registration Filing


Korro Bio Registration statement: Registration Filing

Dec 1, 2023, 7:00 AM EST - 2 years ago

Korro Bio Registration statement: Registration Filing


Korro Bio Appoints Dr. Rachel Meyers to Board of Directors

Nov 28, 2023, 8:00 AM EST - 2 years ago

Korro Bio Appoints Dr. Rachel Meyers to Board of Directors


Korro Bio Registration statement: Registration Filing

Nov 6, 2023, 7:00 AM EST - 2 years ago

Korro Bio Registration statement: Registration Filing


Korro Bio Quarterly report: Q3 2023

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Korro Bio Quarterly report: Q3 2023


Korro Bio Earnings release: Q3 2023

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Korro Bio Earnings release: Q3 2023


Korro Bio Quarterly report: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

Korro Bio Quarterly report: Q2 2023


Korro Bio Earnings release: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

Korro Bio Earnings release: Q2 2023


Korro Bio and Frequency Therapeutics Announce Merger Agreement

Jul 14, 2023, 6:30 AM EDT - 3 years ago

Korro Bio and Frequency Therapeutics Announce Merger Agreement


Korro Bio Quarterly report: Q1 2023

May 12, 2023, 7:00 AM EDT - 3 years ago

Korro Bio Quarterly report: Q1 2023


Korro Bio Earnings release: Q1 2023

May 12, 2023, 7:00 AM EDT - 3 years ago

Korro Bio Earnings release: Q1 2023


Korro Bio Annual report: Q4 2022

Mar 29, 2023, 7:00 AM EDT - 3 years ago

Korro Bio Annual report: Q4 2022


Korro Bio Earnings release: Q4 2022

Mar 29, 2023, 7:00 AM EDT - 3 years ago

Korro Bio Earnings release: Q4 2022


PhishTourFunds
PhishTourFunds May. 28 at 12:25 AM
0 · Reply
Estimize
Estimize May. 20 at 10:00 AM
Wall St is expecting -1.24 EPS for $KRRO Q2 [Reporting 08/18 BMO] http://www.estimize.com/intro/krro?chart=historical&metric_name=eps&utm_c
0 · Reply
notreload_ai
notreload_ai May. 18 at 1:45 PM
$KRRO $MBLY $PMI $TJX -- THE WSJ
0 · Reply
Struin
Struin May. 14 at 3:00 PM
$KRRO My favorites Krro, Xeris, MLTX and more ONWRF
0 · Reply
Plechovka
Plechovka May. 12 at 1:47 PM
$KRRO wtf
0 · Reply
focafoca99
focafoca99 May. 7 at 11:13 AM
$KRRO released its March 2026 quarter results via a press release attached to the 8‑K.
0 · Reply
Kevinchristopher09
Kevinchristopher09 May. 1 at 7:12 PM
$KRRO Been here for awhile roughly $6 average. holding for awhile too
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 12:33 PM
$KRRO Share Price: $12.64 Contract Selected: Dec 18, 2026 $10 Calls Buy Zone: $4.51 – $5.58 Target Zone: $8.39 – $10.25 Potential Upside: 75% ROI Time to Expiration: 231 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 29 at 12:41 AM
$KRRO Current Stock Price: $12.81 Contracts to trade: $12.5 KRRO May 15 2026 Call Entry: $0.25 Exit: $0.40 ROI: 60% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StockConsultant
StockConsultant Apr. 16 at 1:04 PM
$ICLR Icon stock, with an upside gap breakout, target 134+, similar setup on $GO $KD $KRRO and $OLMA stocks at https://stockconsultant.com/?ICLR
0 · Reply
focafoca99
focafoca99 Apr. 11 at 9:01 PM
$KRRO granted a new employee an inducement option for 15,000 shares at a $13.46 exercise price.
0 · Reply
Crypto9999
Crypto9999 Apr. 6 at 1:53 PM
$KRRO 💪💪💪💪 $20++++🧲🧲🧲🧲
0 · Reply
prismmarketview
prismmarketview Apr. 2 at 4:32 PM
PRISM Mid-Day Movers: Pharmaceuticals and Global Health are Today’s Leaders. Biodexa Pharmaceuticals (Nasdaq: $BDRX) is surging to about $1.05, up roughly 70% on heavy volume, yet still down over 90% in the past year as it heads into an April 6, 2026 1‑for‑5 ADR reverse split and remains a speculative, catalyst‑driven oncology play in tough‑to‑treat cancers. Lexaria Bioscience (Nasdaq: $LEXX) is trading just under $1.00, up about 17% as investors eye upcoming GLP‑1 catalysts following positive Human Pilot Study #5 data showing its oral DehydraTECH‑liraglutide performed comparably to injected Saxenda and kicking off a 2026 R&D program with new human and multi‑arm animal GLP‑1 studies. Other Notable Movers: BioStem Technologies ( $BSEM) up 16% Korro Bio ( $KRRO) up 10% Lipocine Inc ( $LPCN) down -78% https://prismmarketview.com/prism-mid-day-movers-pharmaceuticals-and-global-health-are-todays-leaders/
0 · Reply
PhishTourFunds
PhishTourFunds Apr. 2 at 1:38 AM
$KRRO M&A 🎯
0 · Reply
Ilygod
Ilygod Mar. 31 at 2:06 PM
$KRRO Next biotech to be bought out.
0 · Reply
Estimize
Estimize Mar. 24 at 10:03 PM
Wall St is expecting -2.07 EPS for $KRRO Q4 [Reporting 03/31 AMC] http://www.estimize.com/intro/krro?chart=historical&metric_name=eps&utm_c
0 · Reply
finshort
finshort Mar. 20 at 10:27 PM
$KRRO $SPY $QQQ insider cluster buying 🔥🔥 https://finshort.com/KRRO/insiders
0 · Reply
lowside
lowside Mar. 20 at 2:00 AM
$KRRO But here’s the part people miss This specific situation is not a “pure signal” 1. It was part of a financing deal Many shares + warrants were bought directly from the company That means: They’re funding the company, not just betting on stock going up 👉 This is different from insiders buying on the open market with their own cash only.
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 18 at 11:30 AM
$KRRO Q4 '25 Earnings Results & Recap Korro Bio anticipates a regulatory filing for KRRO-121 in H2 2026 to commence a first-in-human trial and expects to nominate an AATD development candidate in Q2 2026, with cash runway into H2 2028.
0 · Reply
mikesterz7
mikesterz7 Mar. 16 at 1:32 AM
$KRRO Mohamad Makhzoumi, a ten percent owner of Korro Bio, Inc. has purchased 207,100 shares of common stock at a price of $11.11, for a total value of $2,300,881
0 · Reply
NoMoneyPlayer
NoMoneyPlayer Mar. 16 at 1:09 AM
$KRRO Shit will be lit!!!
0 · Reply
finshort
finshort Mar. 16 at 1:07 AM
$KRRO $SPY HUGE cluster buying. 9 Insiders 🔥🔥🔥🔥 https://finshort.com/KRRO/insiders
0 · Reply